The Estrogen Elixir: A History of Hormone Replacement Therapy in America
In the first complete history of hormone replacement therapy (HRT), Elizabeth Siegel Watkins illuminates the complex and changing relationship between the medical treatment of menopause and cultural conceptions of aging.
Describing the development, spread, and shifting role of HRT in America from the early twentieth century to the present, Watkins explores how the interplay between science and society shaped the dissemination and reception of HRT and how the medicalization—and subsequent efforts toward the demedicalization—of menopause and aging affected the role of estrogen as a medical therapy. Telling the story from multiple perspectives—physicians, pharmaceutical manufacturers, government regulators, feminist health activists, and the media, as well as women as patients and consumers—she reveals the striking parallels between estrogen’s history as a medical therapy and broad shifts in the role of medicine in an aging society.
Today, information about HRT is almost always accompanied by a laundry list of health risks. While physicians and pharmaceutical companies have striven to develop the safest possible treatment for the symptoms of menopause and aging, many specialists question whether HRT should be prescribed at all. Drawing from a wide range of scholarly research, archival records, and interviews, The Estrogen Elixir provides valuable historical context for one of the most pressing debates in contemporary medicine.
1100304942
The Estrogen Elixir: A History of Hormone Replacement Therapy in America
In the first complete history of hormone replacement therapy (HRT), Elizabeth Siegel Watkins illuminates the complex and changing relationship between the medical treatment of menopause and cultural conceptions of aging.
Describing the development, spread, and shifting role of HRT in America from the early twentieth century to the present, Watkins explores how the interplay between science and society shaped the dissemination and reception of HRT and how the medicalization—and subsequent efforts toward the demedicalization—of menopause and aging affected the role of estrogen as a medical therapy. Telling the story from multiple perspectives—physicians, pharmaceutical manufacturers, government regulators, feminist health activists, and the media, as well as women as patients and consumers—she reveals the striking parallels between estrogen’s history as a medical therapy and broad shifts in the role of medicine in an aging society.
Today, information about HRT is almost always accompanied by a laundry list of health risks. While physicians and pharmaceutical companies have striven to develop the safest possible treatment for the symptoms of menopause and aging, many specialists question whether HRT should be prescribed at all. Drawing from a wide range of scholarly research, archival records, and interviews, The Estrogen Elixir provides valuable historical context for one of the most pressing debates in contemporary medicine.
24.49
In Stock
51
The Estrogen Elixir: A History of Hormone Replacement Therapy in America
In the first complete history of hormone replacement therapy (HRT), Elizabeth Siegel Watkins illuminates the complex and changing relationship between the medical treatment of menopause and cultural conceptions of aging.
Describing the development, spread, and shifting role of HRT in America from the early twentieth century to the present, Watkins explores how the interplay between science and society shaped the dissemination and reception of HRT and how the medicalization—and subsequent efforts toward the demedicalization—of menopause and aging affected the role of estrogen as a medical therapy. Telling the story from multiple perspectives—physicians, pharmaceutical manufacturers, government regulators, feminist health activists, and the media, as well as women as patients and consumers—she reveals the striking parallels between estrogen’s history as a medical therapy and broad shifts in the role of medicine in an aging society.
Today, information about HRT is almost always accompanied by a laundry list of health risks. While physicians and pharmaceutical companies have striven to develop the safest possible treatment for the symptoms of menopause and aging, many specialists question whether HRT should be prescribed at all. Drawing from a wide range of scholarly research, archival records, and interviews, The Estrogen Elixir provides valuable historical context for one of the most pressing debates in contemporary medicine.
Elizabeth Siegel Watkins is a professor in the History of Health Sciences at the University of California, San Francisco, and author of On the Pill: A Social History of Oral Contraceptives, 1950–1970, also published by Johns Hopkins.
Table of Contents
Acknowledgments Introduction 1. Beginnings 2. From the ''Neutral Gender'' to ''Feminine Forever'' 3. Selling Estrogen to Doctors 4. Selling Estrogen to Women 5. From Hero to Villain: Estrogen and Endometrial Cancer 6. Enter the Feminists: Informing Women about Estrogen 7. Enter the FDA: A Patient Package Insert for Estrogen 8. Resurrecting Estrogen, I: Osteoporosis and Medical Science 9. Resurrecting Estrogen, II: Osteoporosis and American Culture 10. Skeptics and Believers: Varieties of Women's Responses 11. Weighing the Benefits and Risks of HRT: Estrogen, Heart Disease, and Breast Cancer 12. 1992: The Year of the Menopause 13. Meno-Boomers: Another Generation Confronts Estrogen 14. The ''Gold Standard'': Estrogen and the Randomized Controlled Trials Notes Index